Hikaru Tanaka

Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect

Haruko Masumiya, Toshinori Shijuku, Hikaru Tanaka et al. · European Journal of Pharmacology · 1998 · 78 citations

Medicine, Cardiology, Pharmacology +17

Stomach Carcinogenicity of Caffeic Acid, Sesamol and Catechol in Rats and Mice

Masao Hirose, Shoji Fukushima, Tomoyuki Shirai et al. · Japanese Journal of Cancer Research · 1990 · 65 citations · Full text

Medicine, Oncology, Toxicology +15

Inhibitory effects of 1-<i>O</i>-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[l,2-<i>a</i>: 3′ ,2′ -<i>d</i>]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-<i>f</i>]quinoxaline (MeIQx)

Masao Hirose, Ryohei Hasegawa, Juki Kimura et al. · Carcinogenesis · 1995 · 61 citations

Medicine, Pharmacology, Toxicology +16

Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz[a]anthracene-induced mammary gland carcinogenesis in female Sprague–Dawley rats

Hikaru Tanaka, Masao Hirose, Mayumi Kawabe et al. · Cancer Letters · 1997 · 47 citations

Medicine, Pharmacology, Toxicology +16

Involvement of maxi-KCa channel activation in atrial natriuretic peptide-induced vasorelaxation

Yoshio Tanaka, Miwako Aida, Hikaru Tanaka et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1998 · 41 citations

Medicine, Cardiology, Pharmacology +10